$SIBN
SI-BONE Inc Stock $sibn

$sibn Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-Q Financial Statement

#000145983919000044 Filed on November 12, 2019

Income Statement

Concept	2019 Q4	2019 Q3	2018 Q3
Revenue	$19.81M	$16.18M	$13.38M
YoY Change	26.82%	20.93%	14.53%
Cost Of Revenue	$2.050M	$1.630M	$1.221M
YoY Change	48.55%	33.5%	-8.06%
Gross Profit	$17.77M	$14.55M	$12.16M
YoY Change	24.79%	19.67%	17.43%
Gross Profit Margin	89.7%	89.93%	90.88%
Selling, General & Admin	$24.47M	$23.26M	$13.83M
YoY Change	43.52%	68.17%	-0.7%
% of Gross Profit	137.7%	159.83%	113.74%
Research & Development	$1.780M	$1.874M	$1.373M
YoY Change	18.67%	36.49%	-6.34%
% of Gross Profit	10.02%	12.88%	11.29%
Depreciation & Amortization	$200.0K	$200.0K	$200.0K
YoY Change	11.11%	0.0%	-33.33%
% of Gross Profit	1.13%	1.37%	1.64%
Operating Expenses	$26.25M	$25.13M	$15.20M
YoY Change	41.51%	65.31%	-1.23%
Operating Profit	-$8.480M	-$10.58M	-$3.044M
YoY Change	96.75%	247.6%	-39.59%
Interest Expense	-$740.0K	$1.243M	$1.282M
YoY Change	4.23%	-3.04%	27.56%
% of Operating Profit
Other Income/Expense, Net	$130.0K	-$94.00K	-$535.0K
YoY Change	-144.83%	-82.43%	-268.77%
Pretax Income	-$9.100M	-$11.31M	-$4.790M
YoY Change	71.37%	136.12%	-15.67%
Income Tax
% Of Pretax Income
Net Earnings	-$9.100M	-$11.31M	-$4.792M
YoY Change	71.37%	135.93%	-15.68%
Net Earnings / Revenue	-45.94%	-69.87%	-35.81%
Basic Earnings Per Share
Diluted Earnings Per Share	-$363.6K	-$456.0K	-$196.8K
COMMON SHARES
Basic Shares Outstanding	25.01M shares	24.80M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q4	2019 Q3	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$91.78M	$96.22M	$14.00M
YoY Change	-24.91%	587.31%
Cash & Equivalents	$10.44M	$12.61M	$14.00M
Short-Term Investments	$81.35M	$83.61M
Other Short-Term Assets	$2.500M	$1.600M	$700.0K
YoY Change	25.0%	128.57%
Inventory	$5.452M	$4.953M	$3.028M
Prepaid Expenses
Receivables	$11.72M	$9.918M	$7.092M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$111.5M	$112.7M	$24.86M
YoY Change	-18.07%	353.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.954M	$3.025M	$2.048M
YoY Change	83.57%	47.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.300M	$5.300M
YoY Change
Other Assets	$315.0K	$305.0K	$1.486M
YoY Change	-3.08%	-79.48%
Total Long-Term Assets	$5.547M	$8.603M	$3.534M
YoY Change	123.76%	143.44%
TOTAL ASSETS
Total Short-Term Assets	$111.5M	$112.7M	$24.86M
Total Long-Term Assets	$5.547M	$8.603M	$3.534M
Total Assets	$117.0M	$121.3M	$28.40M
YoY Change	-15.53%	327.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.811M	$2.623M	$1.790M
YoY Change	30.99%	46.54%
Accrued Expenses	$11.61M	$10.21M	$7.152M
YoY Change	69.17%	42.77%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.358M
YoY Change
Total Short-Term Liabilities	$18.77M	$12.83M	$8.942M
YoY Change	108.46%	43.52%
LONG-TERM LIABILITIES
Long-Term Debt	$34.87M	$39.16M	$38.90M
YoY Change	-10.52%	0.67%
Other Long-Term Liabilities	$362.0K	$363.0K	$332.0K
YoY Change	0.56%	9.34%
Total Long-Term Liabilities	$35.23M	$39.52M	$39.23M
YoY Change	-10.42%	0.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.77M	$12.83M	$8.942M
Total Long-Term Liabilities	$35.23M	$39.52M	$39.23M
Total Liabilities	$54.00M	$52.36M	$49.28M
YoY Change	11.74%	6.25%
SHAREHOLDERS EQUITY
Retained Earnings	-$195.6M	-$186.5M	-$151.9M
YoY Change	24.43%	22.77%
Common Stock	$3.000K	$3.000K	$1.000K
YoY Change	0.0%	200.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$63.01M	$68.96M	-$139.4M
YoY Change
Total Liabilities & Shareholders Equity	$117.0M	$121.3M	$28.40M
YoY Change	-15.53%	327.24%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2018 Q3
OPERATING ACTIVITIES
Net Income	-$9.100M	-$11.31M	-$4.792M
YoY Change	71.37%	135.93%	-15.68%
Depreciation, Depletion And Amortization	$200.0K	$200.0K	$200.0K
YoY Change	11.11%	0.0%	-33.33%
Cash From Operating Activities	-$9.040M	-$7.120M	-$2.530M
YoY Change	43.04%	181.42%	-36.27%
INVESTING ACTIVITIES
Capital Expenditures	-$810.0K	-$750.0K	-$60.00K
YoY Change	406.25%	1150.0%	-40.0%
Acquisitions
YoY Change
Other Investing Activities	$6.380M	$8.480M
YoY Change	-106.59%
Cash From Investing Activities	$5.570M	$7.730M	-$60.00K
YoY Change	-105.74%	-12983.33%	-40.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.250M	580.0K	420.0K
YoY Change	-98.91%	38.1%	-146.15%
NET CHANGE
Cash From Operating Activities	-9.040M	-7.120M	-2.530M
Cash From Investing Activities	5.570M	7.730M	-60.00K
Cash From Financing Activities	1.250M	580.0K	420.0K
Net Change In Cash	-2.220M	1.190M	-2.170M
YoY Change	-119.91%	-154.84%	-56.43%
FREE CASH FLOW
Cash From Operating Activities	-$9.040M	-$7.120M	-$2.530M
Capital Expenditures	-$810.0K	-$750.0K	-$60.00K
Free Cash Flow	-$8.230M	-$6.370M	-$2.470M
YoY Change	33.6%	157.89%	-36.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q3	us-gaap	Purchase Obligation PurchaseObligation	300000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001459839
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25005329	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SI-BONE, Inc.
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
CY2018Q1	sibn	Adjustmentsto Additional Paidin Capital Sharebased Compensation Vesting Of Early Exercised Stock Options AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationVestingOfEarlyExercisedStockOptions	20000	USD
CY2018Q2	sibn	Adjustmentsto Additional Paidin Capital Sharebased Compensation Vesting Of Early Exercised Stock Options AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationVestingOfEarlyExercisedStockOptions	8000	USD
CY2018Q3	sibn	Adjustmentsto Additional Paidin Capital Sharebased Compensation Vesting Of Early Exercised Stock Options AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationVestingOfEarlyExercisedStockOptions	36000	USD
CY2019Q1	sibn	Adjustmentsto Additional Paidin Capital Sharebased Compensation Vesting Of Early Exercised Stock Options AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationVestingOfEarlyExercisedStockOptions	66000	USD
CY2019Q2	sibn	Adjustmentsto Additional Paidin Capital Sharebased Compensation Vesting Of Early Exercised Stock Options AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationVestingOfEarlyExercisedStockOptions	56000	USD
CY2019Q3	sibn	Adjustmentsto Additional Paidin Capital Sharebased Compensation Vesting Of Early Exercised Stock Options AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationVestingOfEarlyExercisedStockOptions	39000	USD
CY2018Q4	sibn	Available For Sale Debt Securities Current Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax	17000	USD
CY2019Q3	sibn	Available For Sale Debt Securities Current Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax	47000	USD
CY2018Q4	sibn	Available For Sale Debt Securities Current Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax	7000	USD
CY2019Q3	sibn	Available For Sale Debt Securities Current Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax	12000	USD
CY2018Q4	sibn	Available For Sale Debt Securities Current Amortized Cost Basis AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis	97093000	USD
CY2019Q3	sibn	Available For Sale Debt Securities Current Amortized Cost Basis AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis	83574000	USD
CY2019Q3	sibn	Available For Sale Debt Securities Noncurrent Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesNoncurrentAccumulatedGrossUnrealizedGainBeforeTax	22000	USD
CY2019Q3	sibn	Available For Sale Debt Securities Noncurrent Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesNoncurrentAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2019Q3	sibn	Available For Sale Debt Securities Noncurrent Amortized Cost Basis AvailableForSaleDebtSecuritiesNoncurrentAmortizedCostBasis	5251000	USD
	sibn	Initial Public Offering Costs Incurred But Not Yet Paid InitialPublicOfferingCostsIncurredButNotYetPaid	865000	USD
	sibn	Initial Public Offering Costs Incurred But Not Yet Paid InitialPublicOfferingCostsIncurredButNotYetPaid	0	USD
CY2018Q4	sibn	Liability For Early Exercise Of Options Current LiabilityForEarlyExerciseOfOptionsCurrent	331000	USD
CY2018Q4	sibn	Liability For Early Exercise Of Options Current LiabilityForEarlyExerciseOfOptionsCurrent	300000	USD
CY2019Q3	sibn	Liability For Early Exercise Of Options Current LiabilityForEarlyExerciseOfOptionsCurrent	133000	USD
CY2019Q3	sibn	Liability For Early Exercise Of Options Current LiabilityForEarlyExerciseOfOptionsCurrent	100000	USD
CY2018Q4	sibn	Marketable Securities Accumulated Gross Unrealized Gain Before Tax MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	17000	USD
CY2019Q3	sibn	Marketable Securities Accumulated Gross Unrealized Gain Before Tax MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	69000	USD
CY2018Q4	sibn	Marketable Securities Accumulated Gross Unrealized Loss Before Tax MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	7000	USD
CY2019Q3	sibn	Marketable Securities Accumulated Gross Unrealized Loss Before Tax MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	12000	USD
CY2018Q4	sibn	Marketable Securities Amortized Cost MarketableSecuritiesAmortizedCost	119951000	USD
CY2019Q3	sibn	Marketable Securities Amortized Cost MarketableSecuritiesAmortizedCost	97781000	USD
CY2018Q4	sibn	Marketable Securities Fair Value MarketableSecuritiesFairValue	119961000	USD
CY2019Q3	sibn	Marketable Securities Fair Value MarketableSecuritiesFairValue	97838000	USD
	sibn	Payments For Repurchase Of Unvested Early Exercised Stock Options PaymentsForRepurchaseOfUnvestedEarlyExercisedStockOptions	0	USD
	sibn	Payments For Repurchase Of Unvested Early Exercised Stock Options PaymentsForRepurchaseOfUnvestedEarlyExercisedStockOptions	38000	USD
CY2018Q4	sibn	Share Based Compensation Arrangement By Share Based Payment Award Options Early Exercise Common Stock Subject To Repurchase ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase	74019	shares
CY2019Q3	sibn	Share Based Compensation Arrangement By Share Based Payment Award Options Early Exercise Common Stock Subject To Repurchase ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase	29268	shares
CY2019Q2	sibn	Stock Issued During Period Amount Restricted Stock Units StockIssuedDuringPeriodAmountRestrictedStockUnits	0	USD
CY2019Q3	sibn	Stock Issued During Period Amount Restricted Stock Units StockIssuedDuringPeriodAmountRestrictedStockUnits	0	USD
CY2018Q2	sibn	Stock Issued During Period Value Unvested Stock Options Exercised StockIssuedDuringPeriodValueUnvestedStockOptionsExercised	0	USD
CY2019Q3	sibn	Stock Repurchased During Period Originally Issued For Exercise Of Unvested Stock Options Value StockRepurchasedDuringPeriodOriginallyIssuedForExerciseOfUnvestedStockOptionsValue	0	USD
	sibn	Vesting Of Early Exercised Stock Options VestingOfEarlyExercisedStockOptions	64000	USD
	sibn	Vesting Of Early Exercised Stock Options VestingOfEarlyExercisedStockOptions	161000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2146000	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2623000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8486000	USD
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9918000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1288000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6860000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10211000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	583000	USD
CY2019Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	730000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3364000	USD
CY2019Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3659000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	439000	USD
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	475000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	246927000	USD
CY2019Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	254965000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	391000	USD
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	363000	USD
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	327000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1871000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1814000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1911000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	160000	USD
CY2018Q4	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1200000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	328000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1081000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1911000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5596000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	263000	USD
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	310000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	194000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	194000	USD
CY2018Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15142061	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15142061	shares
CY2019Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3609984	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3609984	shares
CY2018Q4	us-gaap	Assets Assets	138521000	USD
CY2019Q3	us-gaap	Assets Assets	121316000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	136042000	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	112713000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	97103000	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	83609000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	5273000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	35000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	31000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25120000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12614000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22408000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14004000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25120000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12614000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8404000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12506000	USD
CY2018Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	22858000	USD
CY2019Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	8956000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24450757	shares
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24965512	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24450757	shares
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24965512	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	3000	USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	3000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4796000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12111000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11347000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-29269000	USD
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1221000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3451000	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1630000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4744000	USD
CY2019Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	40000000	USD
CY2019Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	842000	USD
CY2018Q3	us-gaap	Depreciation Depreciation	200000	USD
	us-gaap	Depreciation Depreciation	500000	USD
CY2019Q3	us-gaap	Depreciation Depreciation	200000	USD
	us-gaap	Depreciation Depreciation	600000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	536000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	570000	USD
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.29
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.34
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.46
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.19
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-52000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-64000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5425000	USD
CY2019Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6097000	USD
CY2019Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	6300000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	681000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-95000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-152000	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3226000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8198000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6816000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15776000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	12160000	USD
	us-gaap	Gross Profit GrossProfit	36305000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	14552000	USD
	us-gaap	Gross Profit GrossProfit	42746000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-884000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	526000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-354000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1383000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1844000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3525000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	458000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1575000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-495000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-394000	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	1282000	USD
	us-gaap	Interest Expense InterestExpense	3826000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	1243000	USD
	us-gaap	Interest Expense InterestExpense	3706000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	3343000	USD
CY2019Q3	us-gaap	Inventory Net InventoryNet	4953000	USD
CY2018Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	69000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	199000	USD
CY2019Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	612000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2051000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	48329000	USD
CY2019Q3	us-gaap	Liabilities Liabilities	52355000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	138521000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	121316000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9006000	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	12834000	USD
CY2018Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	0	USD
CY2019Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent	2500000	USD
CY2019Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent	2500000	USD
CY2019Q3	us-gaap	Long Term Debt LongTermDebt	39158000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	77747000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	68961000	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	17778000	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	17778000	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	4444000	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	38963000	USD
CY2019Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	39158000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	627000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2236000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-777000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7916000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8202000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22594000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-4201000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-3147000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-4792000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12140000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-9345000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-8654000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-11306000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-29305000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	15204000	USD
	us-gaap	Operating Expenses OperatingExpenses	43963000	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	25133000	USD
	us-gaap	Operating Expenses OperatingExpenses	70264000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3044000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7658000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-10581000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-27518000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	5217000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	831000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	884000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	958000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1071000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1178000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	295000	USD
CY2018Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	300000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	900000	USD
CY2019Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	300000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	900000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	133000	USD
CY2019Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	405000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	325000	USD
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	305000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2019Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	25000	USD
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-4000	USD
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-11000	USD
CY2019Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	59000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-37000	USD
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	47000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-21000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	54000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-4000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	29000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-19000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	12000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	360000	USD
CY2019Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	363000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-535000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-855000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-94000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-132000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	288000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	167000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	107545000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	777000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1639000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1990000	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1619000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	117100000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	915000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1178000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1263000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5518000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6684000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2154000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3025000	USD
CY2018Q4	us-gaap	Purchase Obligation PurchaseObligation	200000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1373000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3875000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1874000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5503000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-157177000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-186482000	USD
CY2018Q3	us-gaap	Revenues Revenues	13381000	USD
	us-gaap	Revenues Revenues	39756000	USD
CY2019Q3	us-gaap	Revenues Revenues	16182000	USD
	us-gaap	Revenues Revenues	47490000	USD
CY2018Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	388000	USD
CY2019Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	346000	USD
CY2018Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10605000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	31890000	USD
CY2019Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	16443000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	48985000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1081000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5596000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	96496	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	9.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	638983	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.48
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.47
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.43
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.78
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2641198	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2824485	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.27
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.98
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.29
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.89
CY2018Q4	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	12066654	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	359200	shares
CY2019Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1263000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	18000	USD
CY2018Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	190000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	707000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	125000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	442000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	611000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-129378000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	-133171000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	-135703000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	-139429000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	90192000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	82755000	USD
CY2018Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0556
CY2017Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	118548000	USD
CY2018Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	118548000	USD
CY2018Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	118548000	USD
CY2018Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	118548000	USD
CY2017Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	11871578	shares
CY2018Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	11871578	shares
CY2018Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	11871578	shares
CY2018Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	11871578	shares
CY2018Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	3712876	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	3638905	shares
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24803452	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24596788	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:174%;padding-top:12px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents. The Company’s cash and cash equivalents are deposited with financial institutions in the United States and in Europe; the majority of the Company’s cash and cash equivalents are deposited with a single financial institution in the United States. Deposits in this institution exceed the amount of insurance provided on such deposits. The Company has not experienced any losses on its deposits of cash and cash equivalents.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s revenue and accounts receivable are spread across a large number of customers, primarily in the United States, and no one customer accounts for more than 10% of total revenue or gross accounts receivable in any period presented.</font></div></div>
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">The Company and Nature of Business</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SI-BONE, Inc. (the “Company”) was incorporated in the state of Delaware on March 18, 2008 and is headquartered in Santa Clara, California. The Company is a medical device company that has pioneered a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of the most common types of sacroiliac joint disorders that cause lower back pain. The Company introduced its primary product, the iFuse Implant System, or iFuse, in 2009 in the United States, in 2010 in certain countries in the European Union, and in 2015 in certain countries in the rest of the world.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;padding-left:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reverse Stock Split</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2018, the Company's board of directors and stockholders approved a 1-for-18 reverse stock split of the Company's common stock and redeemable convertible preferred stock, which was effected on October 4, 2018. The par value of the common stock and redeemable convertible preferred stock was not adjusted as a result of the reverse split. All issued and outstanding share and per share amounts of common stock, redeemable convertible preferred stock, stock options, and warrants included in the accompanying condensed consolidated financial statements have been adjusted to reflect this reverse stock split for all periods presented.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;padding-left:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Initial Public Offering </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 16, 2018, the Company’s Registration Statement on Form S-1 (File No. 333-227445) relating to the initial public offering (IPO) of its common stock was declared effective by the Securities and Exchange Commission (SEC). Pursuant to such Registration Statement, the Company sold </font><font style="font-family:inherit;font-size:10pt;">8,280,000</font><font style="font-family:inherit;font-size:10pt;"> shares at an initial public offering price of </font><font style="font-family:inherit;font-size:10pt;">$15.00</font><font style="font-family:inherit;font-size:10pt;"> per share for net proceeds of </font><font style="font-family:inherit;font-size:10pt;">$113.4 million</font><font style="font-family:inherit;font-size:10pt;"> to the Company, net of underwriting discounts and commissions and offering costs. Upon the closing of the IPO, the Company's outstanding shares of redeemable convertible preferred stock were automatically converted into an aggregate of </font><font style="font-family:inherit;font-size:10pt;">12,066,654</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock and the Company's outstanding warrants to purchase </font><font style="font-family:inherit;font-size:10pt;">156,550</font><font style="font-family:inherit;font-size:10pt;"> shares of redeemable convertible preferred stock were automatically converted into warrants to purchase an aggregate of </font><font style="font-family:inherit;font-size:10pt;">160,657</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock, resulting in reclassification of the related redeemable convertible preferred stock warrant liability of </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> in additional paid-in-capital.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;padding-left:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant accounting estimates and management judgments reflected in the consolidated financial statements include: fair value of assets and liabilities; analysis of the allowance for doubtful accounts; inventory valuation; valuation of deferred tax assets, including related valuation allowances; fair value of common stock and redeemable convertible preferred stock warrants; stock-based compensation; and useful lives of long lived assets. Estimates are based on historical experience, where applicable and other assumptions believed to be reasonable by the management. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001459839-19-000044-index-headers.html	Edgar Link	pending
0001459839-19-000044-index.html	Edgar Link	pending
0001459839-19-000044.txt	Edgar Link	pending
0001459839-19-000044-xbrl.zip	Edgar Link	pending
exhibit102amendmenttores.htm	Edgar Link	pending
exhibit102amendmenttores001.jpg	Edgar Link	pending
exhibit102amendmenttores002.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sibn-20190930.xml	Edgar Link	completed
sibn-20190930.xsd	Edgar Link	pending
sibn-20190930_cal.xml	Edgar Link	unprocessable
sibn-20190930_def.xml	Edgar Link	unprocessable
sibn-20190930_lab.xml	Edgar Link	unprocessable
sibn-20190930_pre.xml	Edgar Link	unprocessable
sibn-ex311_930201910xq.htm	Edgar Link	pending
sibn-ex312_930201910xq.htm	Edgar Link	pending
sibn-ex321_930201910xq.htm	Edgar Link	pending
sibn930201910-q.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIBN
SI-BONE Inc Stock $sibn

2019 Q4 Form 10-Q Financial Statement

#000145983919000044 Filed on November 12, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIBN SI-BONE Inc Stock $sibn

2019 Q4 Form 10-Q Financial Statement

#000145983919000044 Filed on November 12, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIBN
SI-BONE Inc Stock $sibn